Osl asx

OncoSil Medical Limited.

OncoSil Medical Limited. OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. About the company. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OSL Stock Overview OncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Rewards Risk Analysis. Earnings have declined by

Osl asx

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets. Show more Opinion link Opinion. Show more Personal Finance link Personal Finance. Actions Add to watchlist Add to portfolio Add an alert.

More specifically, Henk has held senior leadership positions in the development of clinical programs for brachytherapy over the past 10 years.

Financial Times Close. Search the FT Search. Show more World link World. Show more US link US. Show more Companies link Companies. Show more Tech link Tech. Show more Markets link Markets.

Market data is provided and copyrighted by Thomson Reuters and Morningstar. Click for restrictions. All rights reserved. ASX shareholders. Our Board. Corporate governance. Media centre. ASX rulebooks. ASX Compliance.

Osl asx

Key events shows relevant news articles on days with large price movements. Polynovo Ltd. PNV 4. Imugene Ltd. IMU 0. Mesoblast Ltd. MSB 7. Actinogen Medical Ltd.

Doctor movie ticket booking pondicherry

Subscribers benefit from access to:. Our Board. OncoSil Medical Ltd. ASX regulatory framework. All markets data located on FT. Add to Your Portfolio New portfolio. Roundup of Global market movements. Market data is provided and copyrighted by Thomson Reuters and Morningstar. How to list. Check our help guide for more info.

Financial Times Close.

He has over publications in peer-reviewed scientific journals, including Lancet and Nature journals. Show more Markets link Markets. In addition, Renzo led the development and set-up of the very first Lu, Y and Sr isotopes radiochemical processes in the industry in the early s. Make up to three selections, then save. Show more Markets link Markets. Market Centre. Director dealings, financials and forecasts are now only available to FT. At OncoSil Medical we have a policy of continuous disclosure. The Company. Debt securities. How to list. Until recently, he was the Group Chief Operating Officer at Telix Pharmaceuticals ASX:TLX a global biopharmaceutical company focused on the development and commercialisation of diagnostic and therapeutic radiopharmaceuticals. Price AUD 0. We encourage our shareholders to attend and participate at our annual general meetings.